Ophthalmic Drugs Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027
The Ophthalmic Drugs Market size is expected to grow at an annual average of 5% during 2021-2027. Ophthalmic drugs are formulations designed to treat eye conditions such as cataracts, glaucoma, color blindness, diabetic macular edema, cytomegalovirus (CMV) retinitis, and age-related macular degeneration (AMD).
The following segmentation are covered in this report:
By Type
- Prescription Drugs
- Over-the-counter Drugs
By Dosage Form
- Liquid Ophthalmic Drug Forms
- Solid Ophthalmic Drug Forms
- Semisolid Ophthalmic Drug Forms
- Multicompartment Drug Delivery Systems
- Other Ophthalmic Drug Forms
By Distribution Channel
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- Others
Company Profile
- AbbVie Inc. (Allergan plc)
- Alcon Inc.
- Bausch & Lomb Incorporated
- F. Hoffmann-La Roche Ltd (Genentech, Inc.)
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Santen Pharmaceutical Co., Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. (Actavis Generics)
Scope of the report
The research study analyses the Ophthalmic Drugs Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Ophthalmic Drugs Market Report
- What was the Ophthalmic Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
- What will be the CAGR of Market during the forecast period (2021-2027)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
- Which manufacturer/vendor/players in the Ophthalmic Drugs Market was the market leader in 2020?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation